Skip to main content
Erschienen in: World Journal of Surgery 1/2018

24.07.2017 | Original Scientific Report

Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma

verfasst von: Masayuki Urabe, Hiroharu Yamashita, Toshiaki Watanabe, Yasuyuki Seto

Erschienen in: World Journal of Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), modified Glasgow prognostic score (mGPS) and prognostic nutritional index (PNI) are simple indices determined employing laboratory data alone and have been used to predict the clinical outcomes of patients with esophagogastric tumors. However, prior results were generally based on analyzing dichotomous data with arbitrary cutoff values. This retrospective study aims to assess prognostic utilities of preoperative NLR, PLR, LMR, mGPS and PNI, as continuous variables, in gastric cancer (GC) and adenocarcinoma of esophagogastric junction (AEG).

Methods

Preoperative data from 1363 patients who underwent surgery for GC/AEG were retrospectively examined. Survival time was evaluated applying the Cox proportional hazard model to both univariate and multivariate estimates of clinicopathological factors and the aforementioned indices as continuous variables.

Results

Preoperatively, each index value was significantly associated with T and N stages, as well as lymphatic involvement and venous involvement. On univariate Cox regression analysis, preoperative NLR, PLR, LMR and PNI were significantly associated with overall survival (OS) and relapse-free survival (RFS). Preoperative mGPS was associated only with RFS. On multivariate Cox regression analysis, preoperative PNI was independently associated with OS and RFS (hazard ratio [HR] 0.62 per 10-unit increase, 95% CI 0.47–0.82, p < 0.001; HR 0.60, 95% CI 0.46–0.78, p < 0.001, respectively), as age, gender, tumor location, T and N stages and venous involvement, while other indices lost independence on multivariate analysis.

Conclusions

Preoperative PNI, a score related to nutritional status, is of importance for predicting long-term outcomes in patients with GC and AEG.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
2.
Zurück zum Zitat Ferro A, Peleteiro B, Malvezzi M et al (2014) Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed Ferro A, Peleteiro B, Malvezzi M et al (2014) Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed
3.
Zurück zum Zitat Kusano C, Gotoda T, Khor CJ et al (2008) Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 23:1662–1665CrossRefPubMed Kusano C, Gotoda T, Khor CJ et al (2008) Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 23:1662–1665CrossRefPubMed
4.
Zurück zum Zitat Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660CrossRefPubMed Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653–660CrossRefPubMed
5.
Zurück zum Zitat van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084CrossRefPubMed
6.
Zurück zum Zitat Shapiro J, van Lanschot JJ, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed Shapiro J, van Lanschot JJ, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090–1098CrossRefPubMed
7.
Zurück zum Zitat Templeton AJ, McNamara MG, Seruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:dju124CrossRefPubMed Templeton AJ, McNamara MG, Seruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:dju124CrossRefPubMed
8.
Zurück zum Zitat Wang SC, Chou JF, Strong VE et al (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg 263:292–297CrossRefPubMedPubMedCentral Wang SC, Chou JF, Strong VE et al (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg 263:292–297CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kim EY, Lee JW, Yoo HM et al (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: Which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22:4363–4370CrossRefPubMed Kim EY, Lee JW, Yoo HM et al (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: Which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22:4363–4370CrossRefPubMed
10.
Zurück zum Zitat Deng Q, He B, Liu X et al (2015) Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med 13:409 Deng Q, He B, Liu X et al (2015) Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med 13:409
11.
Zurück zum Zitat Gu X, Gao XS, Cui M et al (2016) Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer. Oncotarget 7:49878–49887CrossRefPubMedPubMedCentral Gu X, Gao XS, Cui M et al (2016) Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer. Oncotarget 7:49878–49887CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Chan JC, Chan DL, Diakos CI et al (2017) The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg 265:539–546CrossRefPubMed Chan JC, Chan DL, Diakos CI et al (2017) The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg 265:539–546CrossRefPubMed
13.
Zurück zum Zitat Gu L, Li H, Chen L et al (2016) Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget 7:31926–31942CrossRefPubMedPubMedCentral Gu L, Li H, Chen L et al (2016) Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget 7:31926–31942CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hsu JT, Wang CC, Le PH et al (2016) Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomes. J Surg Res 202:284–290CrossRefPubMed Hsu JT, Wang CC, Le PH et al (2016) Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomes. J Surg Res 202:284–290CrossRefPubMed
15.
Zurück zum Zitat Zhou X, Du Y, Xu J et al (2014) The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol 35:11659–11666CrossRefPubMed Zhou X, Du Y, Xu J et al (2014) The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol 35:11659–11666CrossRefPubMed
16.
Zurück zum Zitat Jiang X, Hiki N, Nunobe S et al (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107:275–279CrossRefPubMedPubMedCentral Jiang X, Hiki N, Nunobe S et al (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107:275–279CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Roxburgh CS, Salmond JM, Horgan PG et al (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788–793CrossRefPubMed Roxburgh CS, Salmond JM, Horgan PG et al (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788–793CrossRefPubMed
18.
Zurück zum Zitat McMillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886CrossRefPubMed McMillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886CrossRefPubMed
19.
Zurück zum Zitat Hirashima K, Watanabe M, Shigaki H et al (2014) Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol 49:1040–1046CrossRefPubMed Hirashima K, Watanabe M, Shigaki H et al (2014) Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol 49:1040–1046CrossRefPubMed
20.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMed
21.
Zurück zum Zitat Lee JY, Kim HI, Kim YN et al (2016) Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine 95:e3539CrossRefPubMedPubMedCentral Lee JY, Kim HI, Kim YN et al (2016) Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine 95:e3539CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Migita K, Takayama T, Saeki K et al (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20:2647–2654CrossRefPubMed Migita K, Takayama T, Saeki K et al (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 20:2647–2654CrossRefPubMed
23.
Zurück zum Zitat Kanda M, Mizuno A, Tanaka C et al (2016) Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine 95:e3781CrossRefPubMedPubMedCentral Kanda M, Mizuno A, Tanaka C et al (2016) Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine 95:e3781CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Siewert JR (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 9:173–182CrossRef Siewert JR (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 9:173–182CrossRef
25.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2010) International Union against C. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Hoboken, p 310 Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2010) International Union against C. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Hoboken, p 310
26.
Zurück zum Zitat Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathologica et Microbiologica Scandinavica 64:31–49CrossRefPubMed Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathologica et Microbiologica Scandinavica 64:31–49CrossRefPubMed
27.
Zurück zum Zitat Buzby GP, Mullen JL, Matthews DC et al (1980) Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139:160–167CrossRefPubMed Buzby GP, Mullen JL, Matthews DC et al (1980) Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139:160–167CrossRefPubMed
28.
Zurück zum Zitat Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95:e3164CrossRefPubMedPubMedCentral Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95:e3164CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefPubMed Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefPubMed
30.
Zurück zum Zitat Wagner D, DeMarco MM, Amini N et al (2016) Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg 8:27–40CrossRefPubMedPubMedCentral Wagner D, DeMarco MM, Amini N et al (2016) Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg 8:27–40CrossRefPubMedPubMedCentral
31.
32.
Zurück zum Zitat Tandon P, Low G, Mourtzakis M et al (2016) A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol 14:1473–1480CrossRefPubMed Tandon P, Low G, Mourtzakis M et al (2016) A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol 14:1473–1480CrossRefPubMed
33.
Zurück zum Zitat Reijnierse EM, Trappenburg MC, Leter MJ et al (2015) Serum albumin and muscle measures in a cohort of healthy young and old participants. Age (Dordr) 37:88CrossRef Reijnierse EM, Trappenburg MC, Leter MJ et al (2015) Serum albumin and muscle measures in a cohort of healthy young and old participants. Age (Dordr) 37:88CrossRef
34.
Zurück zum Zitat Baumgartner RN, Koehler KM, Romero L et al (1996) Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 64:552–558PubMed Baumgartner RN, Koehler KM, Romero L et al (1996) Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 64:552–558PubMed
35.
Zurück zum Zitat Otsuji H, Yokoyama Y, Ebata T et al (2015) Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg 39:1494–1500. doi:10.1007/s00268-015-2988-6 CrossRefPubMed Otsuji H, Yokoyama Y, Ebata T et al (2015) Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg 39:1494–1500. doi:10.​1007/​s00268-015-2988-6 CrossRefPubMed
36.
Zurück zum Zitat Vanitallie TB (2003) Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 52:22–26CrossRefPubMed Vanitallie TB (2003) Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 52:22–26CrossRefPubMed
37.
Zurück zum Zitat Fernandez-Garrido J, Navarro-Martinez R, Buigues-Gonzalez C et al (2014) The value of neutrophil and lymphocyte count in frail older women. Exp Gerontol 54:35–41CrossRefPubMed Fernandez-Garrido J, Navarro-Martinez R, Buigues-Gonzalez C et al (2014) The value of neutrophil and lymphocyte count in frail older women. Exp Gerontol 54:35–41CrossRefPubMed
38.
Zurück zum Zitat Urabe M, Yamashita H, Seto Y (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in patients with resectable gastroesophageal junction and gastric cancer. Ann Surg. doi:10.1097/SLA.0000000000001596 Urabe M, Yamashita H, Seto Y (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in patients with resectable gastroesophageal junction and gastric cancer. Ann Surg. doi:10.​1097/​SLA.​0000000000001596​
Metadaten
Titel
Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma
verfasst von
Masayuki Urabe
Hiroharu Yamashita
Toshiaki Watanabe
Yasuyuki Seto
Publikationsdatum
24.07.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 1/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4146-9

Weitere Artikel der Ausgabe 1/2018

World Journal of Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.